The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Freeze-Dried Orally Disintegrating Tablets Market Research Report 2024
Synopsis
Freeze-dried orally disintegrating tablets refer to tablets that do not require water or only need a small amount of water and do not need to be chewed. The tablet is placed on the tongue, and after being quickly dissolved or disintegrated by saliva, the drug can enter the stomach and take effect by swallowing power. . Drugs in this dosage form can be absorbed through the oral cavity or mucous membrane in the esophagus, and the bioavailability is higher than that of ordinary preparations, and the side effects caused by first-pass metabolism can also be reduced. It also has the characteristics of convenient administration, quick onset, and local therapeutic effect, thus becoming a research hotspot in the field of new dosage forms. This novel dosage form is most suitable for children, elderly, bedridden and severely disabled patients. There are many kinds of oral rapidly disintegrating tablets that have been developed abroad, including loratadine (trade name Claritin RediTabs), fatidine (trade name Pepcid ODT), Aoqiping (trade name Zyprexa ZYDIS), loratadine (trade name) Dimetapp ND), Ensistone (Zofran ODT), etc.
Global Freeze-Dried Orally Disintegrating Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Freeze-Dried Orally Disintegrating Tablets market research.
Key manufacturers engaged in the Freeze-Dried Orally Disintegrating Tablets industry include Pfizer, Eli Lilly and Company, Takeda Pharmaceutical, Astellas Pharma, Neos Therapeutics, Janssen, Catalent Pharma Solutions, Salix Pharmaceuticals and Elan, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Freeze-Dried Orally Disintegrating Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Freeze-Dried Orally Disintegrating Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Freeze-Dried Orally Disintegrating Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Eli Lilly and Company
Takeda Pharmaceutical
Astellas Pharma
Neos Therapeutics
Janssen
Catalent Pharma Solutions
Salix Pharmaceuticals
Elan
APOTEX
Beijing Sunho Pharmaceutical
Quantum Hi-tech(China) Pharmaceutical
KV Pharmaceutical
Biovail Corporation
SPl Pharma
Segment by Type
Prescription Drugs
Non-Prescription Drugs
Segment by Application
Medical Field
Health Field
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Freeze-Dried Orally Disintegrating Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Freeze-dried orally disintegrating tablets refer to tablets that do not require water or only need a small amount of water and do not need to be chewed. The tablet is placed on the tongue, and after being quickly dissolved or disintegrated by saliva, the drug can enter the stomach and take effect by swallowing power. . Drugs in this dosage form can be absorbed through the oral cavity or mucous membrane in the esophagus, and the bioavailability is higher than that of ordinary preparations, and the side effects caused by first-pass metabolism can also be reduced. It also has the characteristics of convenient administration, quick onset, and local therapeutic effect, thus becoming a research hotspot in the field of new dosage forms. This novel dosage form is most suitable for children, elderly, bedridden and severely disabled patients. There are many kinds of oral rapidly disintegrating tablets that have been developed abroad, including loratadine (trade name Claritin RediTabs), fatidine (trade name Pepcid ODT), Aoqiping (trade name Zyprexa ZYDIS), loratadine (trade name) Dimetapp ND), Ensistone (Zofran ODT), etc.
Global Freeze-Dried Orally Disintegrating Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Freeze-Dried Orally Disintegrating Tablets market research.
Key manufacturers engaged in the Freeze-Dried Orally Disintegrating Tablets industry include Pfizer, Eli Lilly and Company, Takeda Pharmaceutical, Astellas Pharma, Neos Therapeutics, Janssen, Catalent Pharma Solutions, Salix Pharmaceuticals and Elan, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Freeze-Dried Orally Disintegrating Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Freeze-Dried Orally Disintegrating Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Freeze-Dried Orally Disintegrating Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Eli Lilly and Company
Takeda Pharmaceutical
Astellas Pharma
Neos Therapeutics
Janssen
Catalent Pharma Solutions
Salix Pharmaceuticals
Elan
APOTEX
Beijing Sunho Pharmaceutical
Quantum Hi-tech(China) Pharmaceutical
KV Pharmaceutical
Biovail Corporation
SPl Pharma
Segment by Type
Prescription Drugs
Non-Prescription Drugs
Segment by Application
Medical Field
Health Field
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Freeze-Dried Orally Disintegrating Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Freeze-Dried Orally Disintegrating Tablets Market Overview
1.1 Product Overview and Scope of Freeze-Dried Orally Disintegrating Tablets
1.2 Freeze-Dried Orally Disintegrating Tablets Segment by Type
1.2.1 Global Freeze-Dried Orally Disintegrating Tablets Market Value Comparison by Type (2023-2029)
1.2.2 Prescription Drugs
1.2.3 Non-Prescription Drugs
1.3 Freeze-Dried Orally Disintegrating Tablets Segment by Application
1.3.1 Global Freeze-Dried Orally Disintegrating Tablets Market Value by Application: (2023-2029)
1.3.2 Medical Field
1.3.3 Health Field
1.3.4 Others
1.4 Global Freeze-Dried Orally Disintegrating Tablets Market Size Estimates and Forecasts
1.4.1 Global Freeze-Dried Orally Disintegrating Tablets Revenue 2018-2029
1.4.2 Global Freeze-Dried Orally Disintegrating Tablets Sales 2018-2029
1.4.3 Global Freeze-Dried Orally Disintegrating Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Freeze-Dried Orally Disintegrating Tablets Market Competition by Manufacturers
2.1 Global Freeze-Dried Orally Disintegrating Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Freeze-Dried Orally Disintegrating Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Freeze-Dried Orally Disintegrating Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Freeze-Dried Orally Disintegrating Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Freeze-Dried Orally Disintegrating Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Freeze-Dried Orally Disintegrating Tablets, Product Type & Application
2.7 Freeze-Dried Orally Disintegrating Tablets Market Competitive Situation and Trends
2.7.1 Freeze-Dried Orally Disintegrating Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Freeze-Dried Orally Disintegrating Tablets Players Market Share by Revenue
2.7.3 Global Freeze-Dried Orally Disintegrating Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Freeze-Dried Orally Disintegrating Tablets Retrospective Market Scenario by Region
3.1 Global Freeze-Dried Orally Disintegrating Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Freeze-Dried Orally Disintegrating Tablets Global Freeze-Dried Orally Disintegrating Tablets Sales by Region: 2018-2029
3.2.1 Global Freeze-Dried Orally Disintegrating Tablets Sales by Region: 2018-2023
3.2.2 Global Freeze-Dried Orally Disintegrating Tablets Sales by Region: 2024-2029
3.3 Global Freeze-Dried Orally Disintegrating Tablets Global Freeze-Dried Orally Disintegrating Tablets Revenue by Region: 2018-2029
3.3.1 Global Freeze-Dried Orally Disintegrating Tablets Revenue by Region: 2018-2023
3.3.2 Global Freeze-Dried Orally Disintegrating Tablets Revenue by Region: 2024-2029
3.4 North America Freeze-Dried Orally Disintegrating Tablets Market Facts & Figures by Country
3.4.1 North America Freeze-Dried Orally Disintegrating Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Freeze-Dried Orally Disintegrating Tablets Sales by Country (2018-2029)
3.4.3 North America Freeze-Dried Orally Disintegrating Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Freeze-Dried Orally Disintegrating Tablets Market Facts & Figures by Country
3.5.1 Europe Freeze-Dried Orally Disintegrating Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Freeze-Dried Orally Disintegrating Tablets Sales by Country (2018-2029)
3.5.3 Europe Freeze-Dried Orally Disintegrating Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Freeze-Dried Orally Disintegrating Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Freeze-Dried Orally Disintegrating Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Freeze-Dried Orally Disintegrating Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Freeze-Dried Orally Disintegrating Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Freeze-Dried Orally Disintegrating Tablets Market Facts & Figures by Country
3.7.1 Latin America Freeze-Dried Orally Disintegrating Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Freeze-Dried Orally Disintegrating Tablets Sales by Country (2018-2029)
3.7.3 Latin America Freeze-Dried Orally Disintegrating Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Freeze-Dried Orally Disintegrating Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Freeze-Dried Orally Disintegrating Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Freeze-Dried Orally Disintegrating Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Freeze-Dried Orally Disintegrating Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Freeze-Dried Orally Disintegrating Tablets Sales by Type (2018-2029)
4.1.1 Global Freeze-Dried Orally Disintegrating Tablets Sales by Type (2018-2023)
4.1.2 Global Freeze-Dried Orally Disintegrating Tablets Sales by Type (2024-2029)
4.1.3 Global Freeze-Dried Orally Disintegrating Tablets Sales Market Share by Type (2018-2029)
4.2 Global Freeze-Dried Orally Disintegrating Tablets Revenue by Type (2018-2029)
4.2.1 Global Freeze-Dried Orally Disintegrating Tablets Revenue by Type (2018-2023)
4.2.2 Global Freeze-Dried Orally Disintegrating Tablets Revenue by Type (2024-2029)
4.2.3 Global Freeze-Dried Orally Disintegrating Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Freeze-Dried Orally Disintegrating Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Freeze-Dried Orally Disintegrating Tablets Sales by Application (2018-2029)
5.1.1 Global Freeze-Dried Orally Disintegrating Tablets Sales by Application (2018-2023)
5.1.2 Global Freeze-Dried Orally Disintegrating Tablets Sales by Application (2024-2029)
5.1.3 Global Freeze-Dried Orally Disintegrating Tablets Sales Market Share by Application (2018-2029)
5.2 Global Freeze-Dried Orally Disintegrating Tablets Revenue by Application (2018-2029)
5.2.1 Global Freeze-Dried Orally Disintegrating Tablets Revenue by Application (2018-2023)
5.2.2 Global Freeze-Dried Orally Disintegrating Tablets Revenue by Application (2024-2029)
5.2.3 Global Freeze-Dried Orally Disintegrating Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Freeze-Dried Orally Disintegrating Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Corporation Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly and Company Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 Takeda Pharmaceutical
6.3.1 Takeda Pharmaceutical Corporation Information
6.3.2 Takeda Pharmaceutical Description and Business Overview
6.3.3 Takeda Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Takeda Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.3.5 Takeda Pharmaceutical Recent Developments/Updates
6.4 Astellas Pharma
6.4.1 Astellas Pharma Corporation Information
6.4.2 Astellas Pharma Description and Business Overview
6.4.3 Astellas Pharma Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Astellas Pharma Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.4.5 Astellas Pharma Recent Developments/Updates
6.5 Neos Therapeutics
6.5.1 Neos Therapeutics Corporation Information
6.5.2 Neos Therapeutics Description and Business Overview
6.5.3 Neos Therapeutics Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Neos Therapeutics Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.5.5 Neos Therapeutics Recent Developments/Updates
6.6 Janssen
6.6.1 Janssen Corporation Information
6.6.2 Janssen Description and Business Overview
6.6.3 Janssen Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Janssen Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.6.5 Janssen Recent Developments/Updates
6.7 Catalent Pharma Solutions
6.6.1 Catalent Pharma Solutions Corporation Information
6.6.2 Catalent Pharma Solutions Description and Business Overview
6.6.3 Catalent Pharma Solutions Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Catalent Pharma Solutions Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.7.5 Catalent Pharma Solutions Recent Developments/Updates
6.8 Salix Pharmaceuticals
6.8.1 Salix Pharmaceuticals Corporation Information
6.8.2 Salix Pharmaceuticals Description and Business Overview
6.8.3 Salix Pharmaceuticals Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Salix Pharmaceuticals Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.8.5 Salix Pharmaceuticals Recent Developments/Updates
6.9 Elan
6.9.1 Elan Corporation Information
6.9.2 Elan Description and Business Overview
6.9.3 Elan Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Elan Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.9.5 Elan Recent Developments/Updates
6.10 APOTEX
6.10.1 APOTEX Corporation Information
6.10.2 APOTEX Description and Business Overview
6.10.3 APOTEX Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 APOTEX Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.10.5 APOTEX Recent Developments/Updates
6.11 Beijing Sunho Pharmaceutical
6.11.1 Beijing Sunho Pharmaceutical Corporation Information
6.11.2 Beijing Sunho Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Description and Business Overview
6.11.3 Beijing Sunho Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Beijing Sunho Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.11.5 Beijing Sunho Pharmaceutical Recent Developments/Updates
6.12 Quantum Hi-tech(China) Pharmaceutical
6.12.1 Quantum Hi-tech(China) Pharmaceutical Corporation Information
6.12.2 Quantum Hi-tech(China) Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Description and Business Overview
6.12.3 Quantum Hi-tech(China) Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Quantum Hi-tech(China) Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.12.5 Quantum Hi-tech(China) Pharmaceutical Recent Developments/Updates
6.13 KV Pharmaceutical
6.13.1 KV Pharmaceutical Corporation Information
6.13.2 KV Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Description and Business Overview
6.13.3 KV Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 KV Pharmaceutical Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.13.5 KV Pharmaceutical Recent Developments/Updates
6.14 Biovail Corporation
6.14.1 Biovail Corporation Corporation Information
6.14.2 Biovail Corporation Freeze-Dried Orally Disintegrating Tablets Description and Business Overview
6.14.3 Biovail Corporation Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Biovail Corporation Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.14.5 Biovail Corporation Recent Developments/Updates
6.15 SPl Pharma
6.15.1 SPl Pharma Corporation Information
6.15.2 SPl Pharma Freeze-Dried Orally Disintegrating Tablets Description and Business Overview
6.15.3 SPl Pharma Freeze-Dried Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 SPl Pharma Freeze-Dried Orally Disintegrating Tablets Product Portfolio
6.15.5 SPl Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Freeze-Dried Orally Disintegrating Tablets Industry Chain Analysis
7.2 Freeze-Dried Orally Disintegrating Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Freeze-Dried Orally Disintegrating Tablets Production Mode & Process
7.4 Freeze-Dried Orally Disintegrating Tablets Sales and Marketing
7.4.1 Freeze-Dried Orally Disintegrating Tablets Sales Channels
7.4.2 Freeze-Dried Orally Disintegrating Tablets Distributors
7.5 Freeze-Dried Orally Disintegrating Tablets Customers
8 Freeze-Dried Orally Disintegrating Tablets Market Dynamics
8.1 Freeze-Dried Orally Disintegrating Tablets Industry Trends
8.2 Freeze-Dried Orally Disintegrating Tablets Market Drivers
8.3 Freeze-Dried Orally Disintegrating Tablets Market Challenges
8.4 Freeze-Dried Orally Disintegrating Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
